XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
A portion of the Company's non-vested share-based payment awards are considered participating securities and as such, the Company is required to use the two-class method for the computation of basic and diluted earnings per share. Under the two-class computation method, net losses are not allocated to participating securities unless the holder of the security has a contractual obligation to share in the losses. The non-vested share-based payment awards are not allocated losses as the awards do not have a contractual obligation to share in losses of the Company.
The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for the three months ended March 31, 2021 and 2020:
 Three Months Ended March 31,
 20212020
BASIC  
Net income attributable to common shareholders
$39,401 $16,536 
Weighted-average number of common shares outstanding - basic
275,416,327 253,038,161 
 
Net income attributable to common shareholders - per common share basic
$0.14 $0.07 
DILUTED
Net income attributable to common shareholders - basic
$39,401 $16,536 
Impact of assumed conversions
240 107 
Net income attributable to common shareholders
$39,641 $16,643 
Weighted-average common shares outstanding - basic
275,416,327 253,038,161 
Effect of dilutive securities:
Shares issuable under forward sales agreements
9,843 — 
Unvested share-based payment awards and options775,108 1,160,994 
OP Units2,852,419 3,148,122 
Weighted-average common shares outstanding - diluted
279,053,697 257,347,277 
Net income attributable to common shareholders - per common share diluted
$0.14 $0.06 
For per common share amounts, all incremental shares are considered anti-dilutive for periods that have a loss from continuing operations attributable to common shareholders. In addition, other common share equivalents may be anti-dilutive in certain periods.